SFA
TLSI icon

Sequoia Financial Advisors’s TriSalus Life Sciences TLSI Stock Holding History

Sequoia Financial Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,456
Closed -$90.5K – 1989
2025
Q3 		$90.5K Buy
+19,456
New +$91.1K ﹤0.01% 1693

Other funds holding TLSI

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sequoia Financial Advisors's TLSI Position: Q4 2025 in Review

Sequoia Financial Advisors sold out of TriSalus Life Sciences (TLSI) in Q4 2025, closing a stake of 19,456 shares — an estimated $90.5K sold.

Sequoia Financial Advisors first reported a position in TLSI in Q3 2025 and held it in 1 quarter. The position peaked at $90.5K in Q3 2025. 67 funds tracked by Wall St. Rank hold TLSI as of Q4 2025.

  • Sequoia Financial Advisors reported no remaining TriSalus Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Sequoia Financial Advisors sold 19,456 TriSalus Life Sciences shares in Q4 2025, an estimated $90.5K.
  • Sequoia Financial Advisors first reported a position in TriSalus Life Sciences in Q3 2025 and held it in 1 quarter.
  • Sequoia Financial Advisors's TriSalus Life Sciences position peaked at $90.5K in Q3 2025.
  • 67 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2025.

Based on Sequoia Financial Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.